Product License Update (BoNT-A)

Product License Update (BoNT-A)

CSP announces major change for qualified healthcare injectors in focal spasticity.A product licence update for the botulinum toxin-A (BoNT-A) medicine Dysport® has been granted and this is now clear that it can be administered by any appropriately trained and...
Annual conference 12-13 September 2019

Annual conference 12-13 September 2019

BNN Paediatrics 2019 meeting- 13th September in Oxford Dear Members, We are pleased to launch BNN Paediatrics. Our first meeting will take place in Oxford. It will be a joint meeting in the morning with our colleagues from BNN, and a dedicated afternoon with plenty of...